DNALite Therapeutics

San Francisco, United States

DNALite Therapeutics is an early-stage preclinical biotechnology company.

Mar 2023

Convertible Note

Biotechnology Genetics Health Care

Top Investors

National Science FoundationUniversity of California BerkeleySOSVSOSV SF & NY (Fka IndieBio)Berkeley Catalyst Fund (BCF)

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about DNALite Therapeutics

Who are DNALite Therapeutics's investors?

DNALite Therapeutics's investors include National Science Foundation, University of California Berkeley, SOSV, SOSV SF & NY (Fka IndieBio), Berkeley Catalyst Fund (BCF).

Where is DNALite Therapeutics headquartered?

DNALite Therapeutics is headquartered in San Francisco, United States.

What does DNALite Therapeutics do?

DNALite Therapeutics is an early-stage preclinical biotechnology company.

What stage is DNALite Therapeutics at?

DNALite Therapeutics is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 7, 2023.

MLA

"DNALite Therapeutics — Funding & Investors." VCBacked, March 7, 2023, https://www.vcbacked.co/company/dnalite-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2023). DNALite Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/dnalite-therapeutics

Wikipedia (cite web)

{{cite web |title=DNALite Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dnalite-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 7, 2023.